Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

SOHO 2022 | Major unmet needs in PTCL

Neha Mehta-Shah • 30 Sep 2022
SOHO 2022
Lymphoma Peripheral T-Cell Lymphoma Rare Diseases T-Cell Lymphoma

Neha Mehta-Shah, MD, Washington University in St Louis, St Louis, MO, gives an overview of unmet needs in peripheral T-cell lymphoma (PTCL), highlighting the need for novel agents and treatment approaches for patients with relapsed/refractory (R/R) disease. This interview took place at the Tenth Annual Meeting of the Society of Hematologic Oncology (SOHO) held in Houston, TX.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

More from Neha Mehta-Shah

4:41
ASCO 2023 rare lymphoma highlights: JACKPOT8, IELSG37, and mogamulizumab + CHOP in ATL
Neha Mehta-Shah • 5 Jun 2023
1:54
Navigating regulatory challenges in developing and approving therapies for rare lymphomas
Neha Mehta-Shah • 5 Jun 2023
1:31
Advantages of bispecific antibodies for lymphoma: mosunetuzumab, epcoritamab & glofitamab
Neha Mehta-Shah • 5 Jun 2023
1:41
SWOG S1826: nivolumab+AVD vs brentuximab vedotin+AVD for advanced stage Hodgkin lymphoma
Neha Mehta-Shah • 5 Jun 2023

Related Videos

3:18
Immune-mediated bone marrow failure diseases & their pathophysiology: aplastic anemia, LR-MDS & PNH
Carlo Dufour • 15 Apr 2024
1:32
Promising novel immunotherapeutic approaches in lymphoma
Gloria Iacoboni • 15 Apr 2024
1:11
Personalized risk assessment for transplantation in primary immunodeficiency disorders
Thomas Fox • 15 Apr 2024
3:03
AlloSCT outcomes after immunotherapy vs chemotherapy in patients with R/R NHL: a retrospective study
Jacopo Mariotti • 15 Apr 2024
The content of VJHemOnc is intended for healthcare professionals